Similar articles

• Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.

  Ferrer M, Torres A, Martínez R, Ramírez P, Polverino E, Montull B, Sialer S, Niederman MS, Agusti A, Menéndez R. Ferrer M, et al. Respirology. 2014 Aug;19(6):929-35. doi: 10.1111/resp.12324. Epub 2014 Jun 9. Respirology. 2014. PMID: 24909304
• Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: a cohort study.

  Salluh JI, Soares M, Coelho LM, Bozza FA, Verdeal JC, Castro-Faria-Neto HC, e Silva JR, Bozza PT, Póvoa P. Salluh JI, et al. J Crit Care. 2011 Apr;26(2):193-200. doi: 10.1016/j.jcrc.2010.07.014. J Crit Care. 2011. PMID: 20889284
• Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis.

  Siemieniuk RA, Meade MO, Alonso-Coello P, Briel M, Evaniew N, Prasad M, Alexander PE, Fei Y, Vandvik PO, Loeb M, Guyatt GH. Siemieniuk RA, et al. Ann Intern Med. 2015 Oct 6;163(7):519-28. doi: 10.7326/M15-0715. Ann Intern Med. 2015. PMID: 26258555 Review.
• Low-dose corticosteroids during severe community-acquired pneumonia: end of the story.

  Ricard JD, Messika J. Ricard JD, et al. Eur Respir J. 2015 Feb;45(2):305-7. doi: 10.1183/09031936.00225414. Eur Respir J. 2015. PMID: 25653260 No abstract available.
• [Efficacy of corticosteroids in the management of community-acquired pneumonia].

  Fleury G, Garin N. Fleury G, et al. Rev Med Suisse. 2010 Oct 20;6(267):1977-8, 1980-1. Rev Med Suisse. 2010. PMID: 21125731 Review. French.